ANNA COLLINS: Open Payments
NPI 1841577509 · ONEIDA, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$430 in 23 payments from 11 companies in 2025. Trend: 2023 $95 · 2024 $276 · 2025 $430
Food & beverage: $430
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 4 | $79 |
| Novo Nordisk Inc | 4 | $78 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $65 |
| GlaxoSmithKline, LLC. | 3 | $53 |
| AstraZeneca Pharmaceuticals LP | 2 | $31 |
| Amgen Inc. | 2 | $28 |
| SANOFI-AVENTIS U.S. LLC | 1 | $28 |
| Lilly USA, LLC | 1 | $19 |
| ANI Pharmaceuticals, Inc. | 1 | $18 |
| Daiichi Sankyo Inc. | 1 | $17 |
Products named: XIFAXAN, UBRELVY, Ozempic, SHINGRIX, OTEZLA, LINZESS, TZIELD, Wegovy.
Industry payments across NY — which companies pay providers there.
